HSV-2-virus

Antiviral activities, ineluding potent inhibition of hepatitis B virus (HBV) replieation, influenza A and influenza B, VZV, measles, HSV-1 and HSV-2 viruses. 

Antiviral activities against influenza A and influenza B, measles, VZV, HSV-1 anti-HSV-2 viruses. Anti-HIV-1 reverse transcriptase (RT) activity. 

Acyclovir is a synthetic purine nucleoside that exhibits in vitro and in vivo inhibition of a nmnber of human viruses. In particular, acyclovir is active against herpes simplex types 1 (HSV-1) and 2 (HSV-2) viruses, varicella zoster virus (VZV), Epstein-Barr virus (EBV), and cytomegalovirus (CMV). The inhibitory activity of acyclovir is highly selective. The enzyme thymidine kinase of normal cells does not effectively use acyclovir, but thymidine kinase encoded by one of the viruses noted... 

Acute infection with Hetpes simplex viruses (HSV) results in painful rashes on skin and mucous membranes. HSV-1 mainly causes cold sores around the mouth (hetpes labialis) or eyes (keratitis), whereas infection by HSV-2 mostly results in sores in the genital or anal area. Less frequently, HSV also causes severe infections in newborns or potentially fatal encephalitis. HSV remains latent and can be reactivated by stress, suppression of the immune system or other infections. 

HSV-2, protein from herpes simplex virus (HSV) IgG, IgA, dlgA or slgA Immunoprotection against genital herpes and vaginal O. sativa + 50... 

For other plant-derived antibodies, stability was shown to be similar to mammalian counterparts. For instance, a humanized anti-herpes simplex virus monoclonal antibody (IgGl) was expressed in soybean and showed stability in human semen and cervical mucus over 24 h similar to the antibody obtained from mammalian cell culture. In addition, the plant-derived and mammalian antibodies were tested in a standard neutralization assay with no apparent differences in their ability to neutralize HSV-2. As glycans may play a role in immune exclusion mechanisms in mucus, the diffusion of these monoclonal antibodies in human cerival mucus was tested. No differences were found in terms of the prevention of vaginal HSV-2 transmission in a mouse model, i.e. the plant-derived antibody provided efficient protection against a vaginal inoculum of HSV-2 [58]. This shows that glycosylation differences do not necessarily affect efficacy. 

The possibility to use the YI sensor for virus detection was explored by monitoring the interaction between a-HSV-1 gG antibody and HSV-1 virus particles. To this end, channel 1 was coated with protein pA as described in Sect. 10.4.2 followed by the immobilization of a a-HSV-1 gG layer on the sensing surface of channel 1. Channel 4 was used as a reference channel. Finally a solution with HSV-1 virus particles at a concentration of 105 particles/ml was added to channel 1. Figure 10.2 shows the phase change measured between channel 1 and reference channel 4, clearly demonstrating the detection of virus particles by the YI sensor (Fig. 10.15). 

Pharmacology Valacyclovir is the hydrochloride salt of L-valyl ester of the antiviral drug acyclovir. Valacyclovir is rapidly converted to acyclovir, which has in vitro and in vivo inhibitory activity against herpes simplex virus types I (HSV-1) and II (HSV-2), and varicella-zoster virus (VZV). In cell culture, acyclovir has the highest antiviral activity against HSV-1, followed by (in decreasing order of potency) HSV-2 and VZV. In vitro, acyclovir triphosphate stops replication of herpes viral DMA in 3 ways 1) Competitive inhibition of viral DMA polymerase 2) incorporation and termination of... 

Pharmacology Penciclovir is an antiviral agent active against herpes viruses. It has in vitro inhibitory activity against herpes simplex virus types 1 (HSV-1) and 2 (HSV-2). 

Acyclovir Zovirax) is a guanine nucleoside analogue most effective against HSV-1 and HSV-2, but it has some activity against VCV, CMV, and EBV. Valacyclovir (Valtrex) is the L-valine ester prodrug of acyclovir. Acyclovir is converted to its active metabolite via three phosphorylation steps. First, viral thymidine kinase converts acyclovir to acyclovir monophosphate. Next, host cell enzymes convert the monophosphate to the diphosphate and then to the active compound, acyclovir triphosphate. Because viral thymidine kinase has a much greater affinity for acyclovir triphosphate than does mammalian thymidine kinase, acyclovir triphosphate accumulates only in virus-infected cells. 

Vidarabine (adenine arabinoside, Vira-A) is an adenine nucleoside analogue containing arabinose in place of ri-bose. It is obtained from cultures of Streptomyces an-tibioticus and has activity against HSV-1, HSV-2, VZV, CMV, HBV, poxviruses, hepadnaviruses, rhabdoviruses, and certain RNA tumor viruses. 

Idoxuridine (9.7) and trifluridine (9.8) are antiviral agents that are phosphorylated to their active form in virus-infected cells, and thus show specificity for two reasons their higher affinity for the viral enzyme, and the higher phosphorylase levels in viral-infected than in normal cells. Both compounds have been used locally on lesions of HSV-1 and HSV-2 (the latter of which causes genital herpes, now reaching epidemic proportions) with fair success. They are rather toxic if administered parenterally, as are all moderately selective antimetabolities. 

EO of Melaleuca alternifolia and eucalyptus exhibited a high level of antiviral activity against Herpes simplex virus type 1 (HSV-1) and Herpes simplex virus type 2 (HSV-2) in a viral suspension test [125]. Also, Santolina insularis EO... 

Acyclovir (Figure 49-2) is an acyclic guanosine derivative with clinical activity against HSV-1, HSV-2, and VZV, but it is approximately 10 times more potent against HSV-1 and HSV-2 than against VZV. In vitro activity against Epstein-Barr virus (EBV), cytomegalovirus (CMV), and human herpesvirus-6 (HHV-6) is present but weaker. 

Famciclovir is the diacetyl ester prodrug of 6-deoxypencidovir, an acyclic guanosine analog (Figure 49-2). After oral administration, famciclovir is rapidly deacetylated and oxidized by first-pass metabolism to penciclovir. It is active in vitro against HSV-1, HSV-2, VZV, EBV, and HBV. As with acyclovir, activation by phosphorylation is catalyzed by the virus-specified thymidine kinase in infected cells, followed by competitive inhibition of the viral DNA polymerase to block DNA synthesis. Unlike acyclovir, however, penciclovir does not cause chain termination. Penciclovir triphosphate has lower affinity for the viral DNA polymerase than acyclovir triphosphate, but it achieves higher intracellular concentrations. The most commonly encountered clinical mutants of HSV are thymidine kinase-deficient these are cross-resistant to acyclovir and famciclovir. 

The high density of negative charges in heparan sulfate brings positively charged molecules of lipoprotein lipase into the vicinity and holds them by electrostatic interactions as well as by sequence-specific interactions with S domains. Such interactions are also central in the first step in the entry of certain viruses (such as herpes simplex viruses HSV-1 and HSV-2) into cells. 

Acyclovir is useful in the treatment of herpes. Oral herpes is caused by the herpes simplex virus 1 (HSV-1), and genital herpes is caused by the herpes simplex virus 2 (HSV-2). More than 90 percent of the world s population is infected with the oral herpes virus, though there are many infected people who do not exhibit symptoms. Genital herpes is the most prevalent nondurable sexually transmitted disease. In the United States, there are about 30 million people infected with HSV-2 and an estimated 200,000 to 500,000 new cases each year. 

Bernstein, D.I. 2000. Effect of route of vaccination with vaccinia virus expressing HSV-2 glycoprotein D on protection from genital HSV-2 infection. Vaccine 18 1351. 

A number of mannose-specific agglutinines (lectins) from Galanthus nivalis, Hippeastrum hybrid, Narcissus pseudonarcissus, Listera ovata, Cymbidium hybrid, Epipactis helleborine, and the N-acetylglucosamine-specific lectin from Urtica dioica have been found to inhibit HIV-1 and HIV-2 infection at similar concentrations as dextran sulfate (IC50 0.2 to 0.6 fig/ml), or even lower (IC50 0.04 to 0.08 pg/ml. Akin to sulfated polysaccharides, the plant lectins also exhibit activity against various enveloped viruses other than HIV, i.e., HSV-1, HSV-2, CMV, RSV, and influenza virus. Plant lectins would primarily interfere with the virus-cell fusion process. Their precise mode of action remains to be resolved. 

Table 6 Infectivity of HSV-1 (Herpes simplex virus) and HSV-2 strains pretreated with different concentrations of dextran sulfate for 1 h at 37 °C...

---